Hope for untreatable chest pain? new drug trial launches
NCT ID NCT04306237
Summary
This study aimed to test a new drug called IMB-1018972 for people with severe, persistent chest pain (refractory angina) that doesn't respond well to standard medications. It planned to see if the drug was safe and if it could help patients exercise longer and have fewer chest pain episodes. The trial was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY ANGINA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Imbria Investigational Site
Boston, Massachusetts, 02110, United States
Conditions
Explore the condition pages connected to this study.